title: Doseof intravitreal bevacizumab [Avastin] used as preoperative adjunct therapy for proliferative diabetic retinopathy.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Stewart
authors.forename: Tania L
authors.initials: TL
authors.lastname: Stewart
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D011300:Preoperative Care
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab